Illumina and Rendu Medicine Announce Strategic Collaboration to Advance Precision Diagnostics for Urinary Tract Infections

Illumina Official WeChat Announcement: On January 16, Illumina, Inc. and Gloriousmed reached a cooperation agreement. Both parties will focus on the field of urinary tract infection pathogen detection, specifically Urinary Pathogen/Resistance Gene Detection (UPIP), to jointly promote the application and development of precision diagnostic solutions.